Company: HRTX
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0000950170-25-060882
Chunk: 68

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 68
---
<div align='center'>The Board of Directors recommends a vote “FOR” approval, on an advisory basis, of the compensation paid to our Named Executive Officers for the fiscal year ended December 31, 2024.</div>

49

<div align='center'>PROPOSAL 4 - ADVISORY VOTE TO APPROVE FREQUENCY OF VOTES TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION</div>

As described in Proposal No. 3 above, our stockholders have the opportunity to cast an advisory vote to approve the compensation of our named executive officers in a so-called Say-on-Pay vote. In accordance with the requirements of Section 14A of the Exchange Act and the related rules of the SEC, this Proposal No. 4 affords stockholders the opportunity to cast an advisory vote on how often we should include a Say-on-Pay proposal in our proxy materials for future annual stockholder meetings or any special stockholder meeting for which we must include executive compensation information in the proxy statement for that meeting.

Our stockholders voted on a similar proposal in 2019 with the majority voting to hold the Say-on-Pay vote every year. Our Board and Compensation Committee continue to believe that Say-on-Pay advisory votes should be conducted each year so that our stockholders may express their views on our executive compensation program and the Compensation Committee can consider such views in its compensation planning for the fiscal year following the Say-on-Pay advisory vote.

Stockholders will have the opportunity to choose among four options (holding the vote every one, two or three years, or abstaining) and, therefore, stockholders will not be voting to approve or disapprove the recommendation of the Board. Stockholders may cast their advisory vote to conduct future Say-on-Pay votes every “1 Year,” “2 Years,” or “3 Years,” or “Abstain.”

As an advisory vote, this proposal is not binding on the Company, the Board, or the Compensation Committee. However, the Compensation Committee and the Board value the opinions expressed by stockholders and will consider the outcome of the vote when making a decision regarding the frequency of conducting future Say-on-Pay votes.

It is expected that the next Say-on-Pay frequency vote will occur at the 2031 annual meeting of stockholders.

Abstentions and broker non-votes will have no effect on the outcome of this proposal.

<div align='center'>The Board of Directors recommends a vote "FOR" future advisory votes on named executive officer compensation to occur every